<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Zoetis gets EU marketing authorisation for new vaccine against PCV2 and M. hyopneumoniae in pigs</title><link>/b/veterinary-news/posts/zoetis-gets-eu-marketing-authorisation-for-new-vaccine-against-pcv2-and-m-hyopneumoniae-in-pigs</link><description> Zoetis has announced that the European Commission has granted the company marketing authorization for CircoMax Myco for the active immunisation of pigs against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae . 
 The company says that CircoMax</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>